Introduction Dalbavancin is a bactericidal lipoglycopeptide active against gram-positives. Its
use has been approved for the treatment of acute bacterial skin and skin structure infections …

Outpatient parenteral antimicrobial therapy (OPAT) has evolved relatively slowly in the UK.
This study describes the OPAT service based in a large UK teaching hospital in Sheffield …

European healthcare systems are under increasing pressure owing to demographic change,
the upsurge of chronic diseases, and declining budgets. Yet the increasing threat posed by …

Health-care systems, food supply chains, and society in general are threatened by the
inexorable rise of antimicrobial resistance. This threat is driven by many factors, one of …

Objectives To know the efficacy of different doses of dalbavancin in acute bacterial skin and
skin-structure infections (ABSSSIs) and versus other antibiotics. Methods We performed a …

Outpatient parenteral antimicrobial therapy (OPAT) is a useful treatment strategy against
Pseudomonas aeruginosa and other multidrug-resistant bacteria. However, it is hindered by …

Background Managing the complex needs of outpatient parenteral antibiotic therapy (OPAT)
patients is challenging and time-consuming. We describe development of multimodal …

Background Antimicrobial stewardship programmes are important in driving safety and
quality of antimicrobial prescribing. The National Antimicrobial Prescribing Survey (NAPS) is …

Many healthcare services that were once only available in acute settings are now common
in the community. Intravenous (IV) therapy is increasingly available as a community service …

Background Intravenous antibiotics, either as outpatient parenteral antimicrobial therapy
(OPAT) or transition of care to community-based management, is a common practice in …